Omeros Corp (GB:0KBU)
LSE:0KBU
UK Market

Omeros Stock Analysis & Ratings

GB:0KBU Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.00 - $0.00
Previous Close$3.01
VolumeN/A
Average Volume (3M)55.00
Market Cap$188.50M
P/E RatioN/A
Beta0.96
Next EarningsAug 11, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart Score2
EPS (TTM)0.00


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

GB:0KBU FAQ

What was Omeros’s price range in the past 12 months?
Omeros lowest stock price was $0.00 and its highest was $0.00 in the past 12 months.
    What is Omeros’s market cap?
    Omeros’s market cap is $188.50M.
      What is Omeros’s price target?
      Currently, no data Available
      What do analysts say about Omeros?
      Omeros’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
        When is Omeros’s upcoming earnings report date?
        Omeros’s upcoming earnings report date is Aug 11, 2022 which is in 80 days.
          How were Omeros’s earnings last quarter?
          Omeros released its earnings results on May 10, 2022. The company reported -$0.53 earnings per share for the quarter, beating the consensus estimate of -$0.657 by $0.127.
            Is Omeros overvalued?
            According to Wall Street analysts Omeros’s price is currently Overvalued.
              Does Omeros pay dividends?
              Omeros does not currently pay dividends.
              What is Omeros’s EPS estimate?
              Omeros’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Omeros have?
              Omeros has 62,730,000 shares outstanding.
                What happened to Omeros’s price movement after its last earnings report?
                Omeros reported an EPS of -$0.53 in its last earnings report, beating expectations of -$0.657. Following the earnings report the stock price went up 8.868%.
                  Which hedge fund is a major shareholder of Omeros?
                  Among the largest hedge funds holding Omeros’s share is Falcon Edge Capital, LP. It holds Omeros’s shares valued at N/A.

                    ---

                    Omeros Stock Analysis

                    Smart Score
                    2
                    Underperform
                    1
                    2
                    3
                    4
                    5
                    6
                    7
                    8
                    9
                    10
                    Price Target
                    No data currently available
                    The Omeros stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Omeros Corp

                    Omeros Corp. operates as a biopharmaceutical company. It engages in the discovery, development, and commercializes of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

                    ---
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Pfizer
                    ChemoCentryx
                    Tenax Therapeutics
                    Protara Therapeutics

                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis